March 18, 2024

GTL Shortlisted for Cancer Research Horizons New Startup of the Year Award

Ground Truth Labs (GTL) has been shortlisted for Cancer Research Horizons' prestigious New Startup of the Year award for 2024, recognizing their promising AI biomarker platform for tissue morphology that aims to revolutionize cancer patient stratification and diagnosis.

We are happy to share that Ground Truth Labs (GTL) has been shortlisted for Cancer Research Horizons New Startup of the Year award for 2024.

This award recognises the most promising companies driving scientific breakthroughs in treatments, diagnostics, and medical devices that improve the lives of cancer patients.

Over the past year, our team has built the foundation of our AI biomarker platform for tissue morphology. This platform marks a significant advance towards precision oncology, unlocking quantitative insights and predictive biomarkers with the potential to revolutionise cancer patient stratification and diagnosis.

We thank our exceptional Ground Truth Labs team, advisors, and partners for their support and shared commitment to our mission.

Wishing all the finalists the best of luck at the award ceremony, taking place March 20, 2024.